
|Videos|October 18, 2020
What keeps you up at night in ophthalmology: Part II
Author(s)Alex Delaney-Gesing
Pharmaceutical representatives share what keeps them up at night within the ophthalmic space.
Advertisement
In this second video installment, pharmaceutical representatives share what keeps them up at night within the ophthalmic and glaucoma space while attending the 2020
Featured: Chris Adams, Diopter Corp (CEO); Daria Lemann-Blumenthal, BELKIN Laser Ltd (CEO); Victor Chan, MB, MS, director of U.S. Surgical Device Commercial Marketing (Santen, Inc); Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline (Allergan).
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Moorfields study reveals sharp rise in glaucoma burden across the UK
2
Why individualized glaucoma care remains essential amid uneven patient awareness
3
Study identifies corneal endothelial changes following mRNA COVID-19 vaccination
4
Nanoscope’s gene therapy, MCO-010 receives Sakigake and Orphan Drug Designations in Japan
5














































